{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T00:10:42Z","timestamp":1793751042647,"version":"4.6.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T00:00:00Z","timestamp":1663113600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004948","name":"Astellas Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004948","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004324","name":"Astellas Pharma Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.maturitas.2022.09.006","type":"journal-article","created":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T00:55:42Z","timestamp":1663980942000},"page":"66-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"special_numbering":"C","title":["Prevalence and quality-of-life burden of vasomotor symptoms associated with menopause: A European cross-sectional survey"],"prefix":"10.1016","volume":"167","author":[{"given":"Rossella E.","family":"Nappi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emad","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lora","family":"Todorova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Rea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Gemmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil M.","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.maturitas.2022.09.006_bb0005","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1097\/gme.0b013e3181967e16","article-title":"Temporal associations of hot flashes and depression in the transition to menopause","volume":"16","author":"Freeman","year":"2009","journal-title":"Menopause"},{"issue":"2","key":"10.1016\/j.maturitas.2022.09.006_bb0010","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.maturitas.2008.12.006","article-title":"Menopause-specific questionnaire assessment in US population-based study shows negative impact on health-related quality of life","volume":"62","author":"Williams","year":"2009","journal-title":"Maturitas"},{"issue":"5","key":"10.1016\/j.maturitas.2022.09.006_bb0015","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/AOG.0b013e318214f0de","article-title":"Duration of menopausal hot flushes and associated risk factors","volume":"117","author":"Freeman","year":"2011","journal-title":"Obstet. Gynecol."},{"issue":"9","key":"10.1016\/j.maturitas.2022.09.006_bb0020","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1097\/GME.0000000000000196","article-title":"Risk of long-term hot flashes after natural menopause: evidence from the Penn ovarian aging study cohort","volume":"21","author":"Freeman","year":"2014","journal-title":"Menopause"},{"issue":"7","key":"10.1016\/j.maturitas.2022.09.006_bb0025","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.2105\/AJPH.2005.066936","article-title":"Longitudinal analysis of the association between vasomotor symptoms and race\/ethnicity across the menopausal transition: study of women's health across the nation","volume":"96","author":"Gold","year":"2006","journal-title":"Am. J. Public Health"},{"issue":"3","key":"10.1016\/j.maturitas.2022.09.006_bb0030","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/13543784.2019.1572114","article-title":"Oral investigational drugs currently in phase I or phase II for the amelioration of menopausal symptoms","volume":"28","author":"Genazzani","year":"2019","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"4","key":"10.1016\/j.maturitas.2022.09.006_bb0035","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1001\/jamainternmed.2014.8063","article-title":"Study of women's health across the nation, duration of menopausal vasomotor symptoms over the menopause transition","volume":"175","author":"Avis","year":"2015","journal-title":"JAMA Intern. Med."},{"issue":"4","key":"10.1016\/j.maturitas.2022.09.006_bb0040","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.maturitas.2007.09.006","article-title":"Healthcare seeking and treatment for menopausal symptoms in the United States","volume":"58","author":"Williams","year":"2007","journal-title":"Maturitas"},{"issue":"4","key":"10.1016\/j.maturitas.2022.09.006_bb0045","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1080\/13697137.2017.1315089","article-title":"Vasomotor symptoms in menopause: a biomarker of cardiovascular disease risk and other chronic diseases?","volume":"20","author":"Biglia","year":"2017","journal-title":"Climacteric"},{"issue":"5","key":"10.1016\/j.maturitas.2022.09.006_bb0050","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/GME.0b013e31827d38a5","article-title":"Impact of the severity of vasomotor symptoms on health status, resource use, and productivity","volume":"20","author":"Whiteley","year":"2013","journal-title":"Menopause"},{"issue":"3","key":"10.1016\/j.maturitas.2022.09.006_bb0055","first-page":"203","article-title":"Epidemiology of the symptoms of menopause - an intercontinental review","volume":"13","author":"Makara-Studzi\u0144\u015bka","year":"2014","journal-title":"Prz. Menopauzalny"},{"issue":"12","key":"10.1016\/j.maturitas.2022.09.006_bb0060","doi-asserted-by":"crossref","first-page":"e4907","DOI":"10.1210\/clinem\/dgaa536","article-title":"Genetic variation and hot flashes: a systematic review","volume":"105","author":"Crandall","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.maturitas.2022.09.006_bb0065","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/09513590600842463","article-title":"The european menopause survey 2005: women's perceptions on the menopause and postmenopausal hormone therapy","volume":"22","author":"Genazzani","year":"2006","journal-title":"Gynecol. Endocrinol."},{"issue":"8","key":"10.1016\/j.maturitas.2022.09.006_bb0070","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/GME.0000000000001793","article-title":"Global cross-sectional survey of women with vasomotor symptoms associated with menopause: prevalence and quality of life burden","volume":"28","author":"Nappi","year":"2021","journal-title":"Menopause"},{"issue":"3","key":"10.1016\/j.maturitas.2022.09.006_bb0085","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0378-5122(96)82006-8","article-title":"A menopause-specific quality of life questionnaire: development and psychometric properties","volume":"24","author":"Hilditch","year":"1996","journal-title":"Maturitas"},{"issue":"5","key":"10.1016\/j.maturitas.2022.09.006_bb0090","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","article-title":"The validity and reproducibility of a work productivity and activity impairment instrument","volume":"4","author":"Reilly","year":"1993","journal-title":"PharmacoEconomics"},{"key":"10.1016\/j.maturitas.2022.09.006_bb0100","series-title":"Menopause Practice: A Clinician's Guide","year":"2019"},{"issue":"3","key":"10.1016\/j.maturitas.2022.09.006_bb0105","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/GME.0000000000000373","article-title":"Algorithm and mobile app for menopausal symptom management and hormonal\/non-hormonal therapy decision making: a clinical decision-support tool from the North American Menopause Society","volume":"22","author":"Manson","year":"2015","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2022.09.006_bb0110","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2147\/IJWH.S39027","article-title":"Burden of vasomotor symptoms in France, Germany, Italy, Spain, and the United Kingdom","volume":"5","author":"Dibonaventura","year":"2013","journal-title":"Int. J. Women's Health"},{"issue":"1","key":"10.1016\/j.maturitas.2022.09.006_bb0115","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejogrb.2006.10.036","article-title":"Women's perception of sexuality around the menopause: outcomes of a European telephone survey","volume":"137","author":"Nappi","year":"2008","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"9","key":"10.1016\/j.maturitas.2022.09.006_bb0120","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1080\/09513590.2019.1582625","article-title":"Vasomotor symptoms and neurovegetative comorbidities on the menopause: insights from an Italian quantitative research","volume":"35","author":"Graziottin","year":"2019","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.maturitas.2022.09.006_bb0125","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.maturitas.2021.03.007","article-title":"What women think about menopause: an Italian survey","volume":"147","author":"Vaccaro","year":"2021","journal-title":"Maturitas"},{"issue":"1","key":"10.1016\/j.maturitas.2022.09.006_bb0130","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3109\/13697137.2011.647840","article-title":"Vaginal Health: Insights, Views & Attitudes (VIVA) - results from an international survey","volume":"15","author":"Nappi","year":"2012","journal-title":"Climacteric"},{"issue":"4","key":"10.1016\/j.maturitas.2022.09.006_bb0135","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.ogc.2018.07.005","article-title":"Vasomotor symptoms across the menopause transition: differences among women","volume":"45","author":"Avis","year":"2018","journal-title":"Obstet. Gynecol. Clin. N. Am."},{"issue":"1","key":"10.1016\/j.maturitas.2022.09.006_bb0140","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40695-022-00073-y","article-title":"Disparities in reproductive aging and midlife health between black and white women: the Study of Women's Health Across the Nation (SWAN)","volume":"8","author":"Harlow","year":"2022","journal-title":"Womens Midlife Health"},{"issue":"7","key":"10.1016\/j.maturitas.2022.09.006_bb0145","first-page":"979","article-title":"Sleep disturbance during the menopausal transition in a multi-ethnic community sample of women","volume":"31","author":"Kravitz","year":"2008","journal-title":"Sleep"},{"issue":"1","key":"10.1016\/j.maturitas.2022.09.006_bb0150","first-page":"19","article-title":"Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition","volume":"10","author":"Kravitz","year":"2003","journal-title":"Menopause"},{"issue":"3","key":"10.1016\/j.maturitas.2022.09.006_bb0155","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.maturitas.2014.07.002","article-title":"Menopausal hormone therapy use in 17 European countries during the last decade","volume":"79","author":"Ameye","year":"2014","journal-title":"Maturitas"},{"issue":"6","key":"10.1016\/j.maturitas.2022.09.006_bb0160","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/GME.0000000000001282","article-title":"Menopausal hormone therapy trends before versus after 2002: impact of the Women's Health Initiative Study Results","volume":"26","author":"Crawford","year":"2018","journal-title":"Menopause"},{"issue":"3","key":"10.1016\/j.maturitas.2022.09.006_bb0165","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Writing Group for the Women's Health Initiative Investigators, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.maturitas.2022.09.006_bb0170","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1210\/jc.2015-2236","article-title":"Treatment of symptoms of the menopause: an Endocrine Society clinical practice guideline","volume":"100","author":"Stuenkel","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.maturitas.2022.09.006_bb0175","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.maturitas.2016.06.001","article-title":"Revised global consensus statement on menopausal hormone therapy","volume":"91","author":"de Villiers","year":"2016","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2022.09.006_bb0180","author":"NICE"},{"issue":"11","key":"10.1016\/j.maturitas.2022.09.006_bb0185","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/GME.0000000000000546","article-title":"Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of The North American Menopause Society","volume":"22","year":"2015","journal-title":"Menopause"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512222002018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512222002018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:21:19Z","timestamp":1759915279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512222002018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":34,"alternative-id":["S0378512222002018"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2022.09.006","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and quality-of-life burden of vasomotor symptoms associated with menopause: A European cross-sectional survey","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2022.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}